February 04, 2026

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

KFF Health News

January 15, 2026

NPs Top US Jobs List Again

The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.

Conexiant

September 19, 2025

Vaccine Playbook Rewrite: Who’s In Charge?

HHS Secretary Robert F. Kennedy Jr.’s changes at the CDC are prompting states and medical societies to issue independent vaccine recommendations, challenging long-standing national immunization policy.

KFF Health News

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

July 26, 2024

Healing and Owing: U.S. Health Workers' $150 Billion Debt Dilemma

A new study exposes the alarming levels of medical and educational debt burdening U.S. health care workers, with debt disproportionately affecting women, Black workers, and those in lower-paying fields.

Conexiant

September 23, 2024

Physicians Urged to Scrutinize Employers Beyond Salary

Beyond salary and work-life balance, physicians seeking new roles should evaluate potential employers' governance, reward systems, and culture, according to a viewpoint published in JAMA Internal Medicine.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

June 24, 2025

Exam Shift Spurs National Rights Battle

Democratic AGs push to relocate OB-GYN exams from Texas, citing threats to reproductive and gender-affirming care under state abortion bans.

KFF Health News

June 26, 2024

FDA Releases Guidance for Drugmakers on Diversity in Clinical Studies

The U.S. Food and Drug Administration issued draft guidance for drugmakers and medical device makers to improve diversity in clinical trials, emphasizing the importance of actions to support more equitable access to medical innovations.

Conexiant